Abstract

The larva of cestodes belonging to the Echinococcus granulosus sensu lato (s.l.) complex causes cystic echinococcosis (CE). It is a globally distributed zoonosis with significant economic and public health impact. The most immunogenic and specific Echinococcus-genus antigen for human CE diagnosis is antigen B (AgB), an abundant lipoprotein of the hydatid cyst fluid (HF). The AgB protein moiety (apolipoprotein) is encoded by five genes (AgB1-AgB5), which generate mature 8 kDa proteins (AgB8/1-AgB8/5). These genes seem to be differentially expressed among Echinococcus species. Since AgB immunogenicity lies on its protein moiety, differences in AgB expression within E. granulosus s.l. complex might have diagnostic and epidemiological relevance for discriminating the contribution of distinct species to human CE. Interestingly, AgB2 was proposed as a pseudogene in E. canadensis, which is the second most common cause of human CE, but proteomic studies for verifying it have not been performed yet. Herein, we analysed the protein and lipid composition of AgB obtained from fertile HF of swine origin (E. canadensis G7 genotype). AgB apolipoproteins were identified and quantified using mass spectrometry tools. Results showed that AgB8/1 was the major protein component, representing 71% of total AgB apolipoproteins, followed by AgB8/4 (15.5%), AgB8/3 (13.2%) and AgB8/5 (0.3%). AgB8/2 was not detected. As a methodological control, a parallel analysis detected all AgB apolipoproteins in bovine fertile HF (G1/3/5 genotypes). Overall, E. canadensis AgB comprised mostly AgB8/1 together with a heterogeneous mixture of lipids, and AgB8/2 was not detected despite using high sensitivity proteomic techniques. This endorses genomic data supporting that AgB2 behaves as a pseudogene in G7 genotype. Since recombinant AgB8/2 has been found to be diagnostically valuable for human CE, our findings indicate that its use as antigen in immunoassays could contribute to false negative results in areas where E. canadensis circulates. Furthermore, the presence of anti-AgB8/2 antibodies in serum may represent a useful parameter to rule out E. canadensis infection when human CE is diagnosed.

Highlights

  • The larval stage of Echinococcus granulosus sensu lato (s.l.) causes cystic echinococcosis (CE, traditionally referred to as hydatid disease), one of the most important and widespread parasitic zoonoses

  • Since recombinant AgB8/2 has been found to be diagnostically valuable for human CE, our findings indicate that its use as antigen in immunoassays could contribute to false negative results in areas where E. canadensis circulates

  • Cystic echinococcosis (CE), a worldwide-spread zoonosis, affects livestock mammals and humans with significant economic and public health impact. It is caused by the infection with the larva of cestodes belonging to Echinococcus granulosus complex, a series of parasite species with preference for different hosts

Read more

Summary

Introduction

The larval stage (metacestode) of Echinococcus granulosus sensu lato (s.l.) causes cystic echinococcosis (CE, traditionally referred to as hydatid disease), one of the most important and widespread parasitic zoonoses It is a fluid-filled cyst that establishes and grows in the host viscera (mainly liver and lung) of several ungulate livestock (among others sheep, cattle, horse, goat, and pig) and wild animals [1]. Phylogenetic studies have led to split E. granulosus s.l. into five species, showing preference for infecting different hosts: E. granulosus sensu stricto (including G1-G3 genotypes), E. equinus (G4), E. ortleppi (G5), E. canadensis (G6–G10) and E. felidis [2,3] These species seem to diverge in their transmission dynamics, morphology, rate of development, antigenicity, sensitivity to drugs and, in their infectivity and pathogenicity in humans, which might influence the design of therapeutic and prophylactic programmes for CE control. These values may be underestimated since E. canadensis seems to exhibit a lower and/or slower growth than E. granulosus s.s. in humans, leading to more benign or asymptomatic infections [3,4]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call